The Use of High Concentration Hyaluronic Acid (HA) Transfer Medium in Repeated Implantation Failure (RIF) Patients
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This is a pilot study with the aim to investigate the beneficial effect of bicarbonate
buffered medium containing hyaluronan and recombinant human albumin (EmbryoGlue®, Vitrolife)
in patients with documented repeated implantation failure on live birth per randomized
subject as primary endpoint.